Correction: The role of gut microbiota mediated ferroptosis in PCOS and the therapeutic potential of Chinese herbal medicine - Report - MDSpire

Correction: The role of gut microbiota mediated ferroptosis in PCOS and the therapeutic potential of Chinese herbal medicine

  • By

  • Yingchun Lv

  • Dongqi Li

  • Ning Ding

  • Hongying Kuang

  • June 5, 2026

  • 0 min

Share

Correction: The Impact of Gut Microbiota-Induced Ferroptosis on PCOS

Overview

This correction addresses the omission of funding information in the original article regarding the role of gut microbiota-mediated ferroptosis in polycystic ovary syndrome (PCOS) and the therapeutic potential of Chinese herbal medicine. The correction ensures proper attribution to the Longjiang Science and Technology Talents Chunyan Support Program.

Background

Polycystic ovary syndrome (PCOS) is a prevalent hormonal disorder affecting 5-10% of women of reproductive age, associated with significant reproductive and metabolic complications. Understanding the mechanisms underlying PCOS, including the role of gut microbiota and ferroptosis, is crucial for developing effective therapeutic strategies. Recent studies have begun to explore the intersection of these factors, highlighting the need for further research.

Data Highlights

No numerical or trial data presented in the correction.

Key Findings

  • The correction acknowledges the omission of funding information for the study on gut microbiota and ferroptosis in PCOS.
  • PCOS is linked to various reproductive and metabolic issues, necessitating comprehensive management strategies.
  • Research indicates that gut microbiota may influence ferroptosis, which is relevant to the pathophysiology of PCOS.
  • Chinese herbal medicine is being investigated for its potential therapeutic effects on PCOS.
  • Further studies are needed to confirm the mechanisms involving gut microbiota and ferroptosis in PCOS.

Clinical Implications

Accurate reporting of funding sources is essential for transparency in research. Understanding the role of gut microbiota and ferroptosis may inform future therapeutic approaches for managing PCOS.

Conclusion

This correction emphasizes the importance of proper funding acknowledgment in research publications and highlights ongoing investigations into the complex mechanisms of PCOS.

Related Resources & Content

  1. Lv, Y., Li, D., Ding, N., Kuang, H., Front. Med, 2026 -- Correction: The Impact of Gut Microbiota-Induced Ferroptosis on PCOS
  2. Frontiers in Immunology — From gut-reproductive microbiota to ferroptosis: a comprehensive insight into the molecular-pathogenicity of endometriosis
  3. European Journal of Preventive Cardiology — Addressing Polycystic Ovary Syndrome to Mitigate Cardiovascular Disease Risk
  4. Frontiers in Reproductive Health — Integrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications
  5. Frontiers in Endocrinology — Effects of Tai Chi combined with dietary intervention on health-promoting lifestyle and metabolic and reproductive outcomes in female college students with polycystic ovary syndrome: a randomized controlled trial
  6. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023) - practice guidance | American Society for Reproductive Medicine | ASRM
  7. Ovarian ferroptosis induced by androgen is involved in pathogenesis of PCOS | Human Reproduction Open | Oxford Academic
  8. Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial | Trials | JAMA | JAMA Network

Original Source(s)

Related Content